Browsing "Pharmacology" by Keyword : Dopaminergic Neurons
Showing results 1 to 8 of 8
| Pub Year | | Title | Author(s) |
| 2015 | | Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease. | 조은혜 |
| 2024 | | Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease | 김동규, 김수정, 박상면, 우현구 |
| 2015 | | Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease. | 박상면, 조은혜, 주일로, 차선희 |
| 2017 | | Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease | 박상면 |
| 2021 | | Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment | 박상면 |
| 2015 | | PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death. | 조은혜, 최인섭 |
| 2020 | | The dual role of c-src in cell-to-cell transmission of alpha-synuclein | 박상면, 조은혜, 주일로, 최유리 |
| 2022 | | Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease | 박상면 |
1
